Clearance Summary
RABBIT ANTISERUM TO HUMAN C4 received FDA 510(k) clearance under submission number K831906, sponsored by Dako Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1983-07-19.
- Submission: K831906
- Applicant / Sponsor: Dako Corp.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5240
- Decision date: 1983-07-19
Classification & Regulation
This clearance is catalogued under FDA product code DBI and 21 CFR 866.5240, within the Immunology review panel as a Class II device.